Dani Instruments Announce Indian Distribution Agreement
Dani Instruments SpA and Labindia Instruments Pvt Ltd have announced an exclusive distribution agreement.
Dani Instruments SpA (Cologno Monzese, Italy) and Labindia Instruments Pvt Ltd (Thane, India) have announced an exclusive distribution agreement. The deal sees Labindia become the exclusive distributor for the gas chromatography (GC) portfolio of Dani Instruments within India.
“Labindia is a great partner and we expect they will deliver a strong growth of our brand in this country,” said Massimiliano Saini Fasanotti, CEO of Dani Instruments SpA. He continued, “They have the scale, infrastructure, reputation, experience, and complementary product portfolio to make Dani a market leader in the Indian market. We are happy that Labindia recognized the quality, robustness, innovation, and breadth of our products.”
Under the terms of the agreement, Labindia will distribute Dani products. There is also scope for the distribution agreement to be expanded with additional products in the near future.
“Labindia is committed to provide its customers advanced chromatographic solutions,” said Shriram Bhalerao, Managing Director Labindia Instruments. “The Dani gas chromatographic portfolio includes unique solutions to address the most demanding customers’ needs. Dani’s portfolio is a perfect fit with our current offer in the analytical market,” added Shriram.
Both companies hope that their combined reputation and experience as well as complementary product profiles can yield a prominent place within the Indian analytical chemistry market.
For more information please visit www.dani-instruments.com or http://www.labindia.com/
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
